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Abstract
Background Therapeutic hypothermia (i.e., temperature
management) is an effective option for improving survival
and neurological outcome after cardiac arrest and is
potentially useful for the care of the critically ill neuro-
logical patient. We analyzed the feasibility of a device to
control the temperature of the brain by controlling the
temperature of the blood flowing through the neck.
Methods A lumped parameter dynamic model, with one-
dimensional heat transfer, was used to predict cooling
effects and to test experimental hypotheses. The cooling
system consisted of a flexible collar and was tested on 4
adult sheep, in which brain and body temperatures were
invasively monitored for the duration of the experiment.
Results Model-based simulations predicted a lowering of
the temperature of the brain and the body following the
onset of cooling, with a rate of 0.4 C/h for the brain and
0.2 C/h for the body. The experimental findings showed
comparable cooling rates in the two body compartments,
with temperature reductions of 0.6 (0.2) C/h for the brain
and 0.6 (0.2) C/h for the body. For a 70 kg adult human
subject, we predict a temperature reduction of 0.64 C/h
for the brain and 0.43 C/h for the body.
Conclusions This work demonstrates the feasibility of
using a non-invasive method to induce brain hypothermia
using a portable collar. This device demonstrated an opti-
mal safety profile and represents a potentially useful
method for the administration of mild hypothermia and
temperature control (i.e., treatment of hyperpyrexia) in
cardiac arrest and critically ill neurologic patients.
Trial Registration: Italian Ministry of Health 351/2015-PR05/11/
2015.
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article (doi:10.1007/s12028-016-0257-7) contains supplementary
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Introduction
Therapeutic hypothermia is recommended to improve the
survival and neurological outcome of patients following
cardiac arrest [1, 2]. However, there is a lack of consensus
on the optimal target temperature, the timing of initiation,
the duration of hypothermia, and the cooling methods [3].
Recent evidence from a randomized clinical trial suggests
no additional benefits, in terms of survival and neurological
outcome, cooling to 36 versus 33 C, which indicates that
mild hypothermia and avoiding hyperthermia could be
sufficient to confer neuroprotection in out-of-hospital car-
diac arrest patients [4]. In this and the other clinical trials
designed to test the effects of hypothermia following car-
diac arrest [4–7], hypothermia was generally obtained with
aggressive cooling by means of methods such as
intravascular and surface cooling devices. While whole-
body cooling is an efficient method to reduce the brain
temperature, it is however poorly tolerated without heavy
sedation and pharmacological treatment of shivering.
Whole-body cooling is also associated with several side
effects, including coagulation disturbances, immunosup-
pression, and cardiovascular instability [8]. As
hypothermia-induced neuroprotection derives from brain
cooling and does not require to cool down the whole body,
local brain cooling represents an attractive, viable and cost-
effective alternative to whole-body hypothermia. More-
over, selective brain cooling is potentially applicable for
prolonged clinical use, for brain selective mild hypother-
mia following cardiac arrest and prevent fever in critically
ill neurologic patients. There is therefore growing interest
in developing novel methods to effectively administer
brain hypothermia and temperature control [8–10].
Accordingly, our objective was to analyze the feasibility of
a portable cooling method to control the temperature of the
brain via controlling the temperature of the blood flowing
through the neck.
Materials and Methods
Our study design incorporated three integrated phases: (1)
the development of a thermodynamic model to simulate
whole-body circulation system for a large animal; (2)
testing of experimental hypotheses on the function of the
neck as a heat exchanger for brain cooling in a large animal
model, using our custom-designed portable cooling system;
(3) and computational adaptation of the thermodynamic
model to predict experimental outcomes for the human
system.
The Thermodynamic Model
A lumped parameter dynamic model, with one-dimensional
heat transfer, was used to predict cooling effects and to test
experimental hypotheses. In this model, the temperature of
each element (i.e., tissue or vessel) was considered to vary
with time but to remain uniform within the tissue or vessel
at any instant. Within this whole-body thermodynamic
model, we considered the head, neck, and body as separate
compartments connected to each other by the cardiovas-
cular system (Fig. 1a) [11]. Heat transfer in any one of
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The first thermodynamic equation describes the
convective transmission of heat between blood and
tissues, while the second equation describes the
transmission of metabolic heat between tissues and the
adjacent bodies (i.e., tissue, cooling element, or




) into a tissue with a convection mass _mb ¼
qb/b (where qb is the blood density, Vi is the volume, cb
the specific heat and /b is the flow) and exchanges heat
with that tissue through the walls of the vessels, depending
on the conductivity of the tissue (git ¼ hbSv). The blood
capability to absorb heat from the tissue is described by its
specific heat cb and convective coefficient hb. The blood
enters at a temperature of Ti1, removes heat from the
tissue at temperature Tt and exits at temperature Ti [13].
The tissue exchange of heat with adjacent bodies (i.e.,
tissue, cooling element, environment) depends on Tj  Tt,
where Tj is the temperature of an adjacent body (i.e., tissue,
cooling element, or environment), Tt defines the tissue
temperature, and its thermal conductivity kt (that is the
property of the tissue to conduct heat) and the heat pro-
duced by the metabolism as indicated in Eq. 2 (Fig. 1b).
The tissue exchanges metabolic heat ( _Qm) through con-
duction (gtj ¼ kt StLt), with adjacent bodies (i.e., tissue,
cooling element, environment).
For metabolic heat generation the basal metabolic heat
_Qm is used in the model [14].
The parameters used in the simulation of our model are
listed in (Supplement Table).
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The Cooling System
A surface cooling system was designed to target the carotid
arteries of the neck. The cooling system consisted of a
flexible collar, powered by a 60 W source. Considering an
average efficiency of 60 % for the system, calculated from
the manufacturer’s datasheets for the cooling elements, a
local heat removal of 36 W was estimated. Figure 2a
illustrates the cooling collar wrapped around the sheep
neck.
Experimental Study on a Large Animal Model
All applicable institutional and/or national guidelines for
the care and use of animals were followed. Housing, hus-
bandry and experimental procedures were approved and
carried out in conformity with the guidelines of the Review
Board for animal studies at the Istituto Superiore di Sanita`
(ISS), and the national guidelines (D.Lgs 26/2014) of the
Italian Ministry of Health and International Laws and
Policies (EEC Council Directive, 2010/63/UE). The study
was authorized by the institutional and ethics review board
of the Italian Ministry of Health (trial registration
351/2015-PR 05/11/2015). The experiments were carried
out at CRABCC, Biotechnology Research Center for Car-
dio-Thoracic Applications (Rivolta D’Adda, Italy).
The prototype of the cooling system was tested on 4
adult Bergamasca sheep (Ovis aries, Bergamasca breed,
1-year-old, 65–70 kg body weight and all female). After
sedation, general anesthesia was induced by ketamine
(2–5 mg/kg intravenous IV); combined with midazolam
(0.5 mg/kg IV) administered by injection into the external
jugular vein. As soon as practical, each animal was intu-
bated and mechanically ventilated. Anesthesia was
maintained with 2–3 % isoflurane in 100 % oxygen. An
orogastric tube was positioned to evacuate gaseous and
liquid gastric contents. Blood pressure was monitored
invasively during the procedure through the cannulation of
the auricular artery in two animals. A thermal blanket was
wrapped around the body of the animal to control the body
temperature during the procedure. The head was then
bFig. 1 Schematic representation of the thermodynamic model of the
whole human body (a), with the inset showing the model for a specific
tissue (b). In this model, the head (h), neck (n), and body (b) are
represented as separate compartments connected to each other by the
cardiovascular system (in red). The temperature of each element (i.e.,
tissue or vessel) was considered to vary with time but to remain
uniform within the tissue or vessel at any instant. T1 and T2 are the
temperatures of the cooling elements of the collar, T3 and T5 are the
temperatures of the blood flowing through the neck (in and out), while
T4 and T6 refer to the temperatures of the blood in head and body,
respectively. Other abbreviations: Tb, Th, Tn, Te—temperatures of the
body, head, neck, and environment, respectively; Qb, Qh, Qm—
metabolic heat of the body, head, and tissue, respectively; g1e, gbe,
ghe, g6b, gbn, gnh, g3n, g5n, g4h, g12, gjt, git—thermal conductivity
between: the device and the environment, the body and the
environment, the head and the environment, the blood and the body,
the body and the neck, the neck and the head, the neck and the blood
flowing to the head, the neck and the blood flowing back from the
head, the blood and the head, the cooling elements of the collar, the
environment and the tissue, the blood and the tissue, respectively;
/—blood flow within each specific segment of the cardiovascular
system. In b, Tt defines the tissue temperature, Tj the temperature of
an adjacent body (i.e., tissue, cooling element, or environment), and
Ti1, Ti the temperature of the blood entering and exiting the tissue.
Note that the thermal conductivities gtj ¼ kt StLt and git ¼ hbSv are
related to the conduction and the convection phenomena, respec-
tively. While _Qm is the basal metabolic heat
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stabilized with adhesive patches, and a burr hole drilled
into the right occipital bone, using a 1.5-mm ball tool
(Medtronic Midas Rex surgical drill), for the placement of
the reference brain temperature sensor (PT-100 ATEX
sensor) 1 cm into the white matter between the parietal and
occipital lobe with a sagittal postero-anterior orientation.
The brain sensor in place is shown in Fig. 2b. The
parenchymal position of the catheter into the cerebral
parenchyma was confirmed by post-mortem inspection of
the brain and no visible signs of brain hemorrhages were
noted in any part of the brain. The burr hole was sealed
with sterile bone wax and the head was covered with sur-
gical blankets to reduce thermal dispersion. Body
temperature was measured using a rectal/esophageal probe.
ECG, pulse oximetry, capnography, invasive blood pres-
sure, and brain and esophageal temperatures were
monitored by an anesthesiologist throughout the procedure
and digitally recorded.
The neck was completely shaved so each carotid artery
was identified using echo Doppler scanning for the place-
ment of the two refrigerating elements. The device was
activated and programmed to reduce skin temperature no
lower than 5 C. Local, brain, and body temperatures were
recorded continuously (1 Hz sampling rate, duration of
3600 s). The system was controlled through feedback using
local temperature sensors. Brain (in situ PT-100 sensor)
and body (esophageal probe) temperatures were recorded
continuously (1 Hz sampling rate, duration of monitoring
3600 s). At the end of the experiment, the cooling collar
was removed and the skin under the cooling elements
visually examined. The animals, still under anesthesia,
were euthanized by IV injection of pentothal sodium
(50 mg/kg) and potassium chloride (20 mg/kg).
Statistical Analysis
Normally distributed variables are expressed as
mean ± standard deviation (SD). The Shapiro–Wilk W test
was used to assess the normality of the distribution of
temperature recordings. Between-group comparisons were
evaluated using two-tailed, Student’s t test, with a P value
<0.05 considered to be significant. All statistical analyses
were performed using Data and Statistical Software
(STATA software version 10.0, Stata Corp., TX, USA).
Results
Model-based simulation of the time series of brain and
body temperatures values is reported in Fig. 3, for both the
sheep and human thermodynamic model. Note that the
experimental data and their confidence intervals are com-
pared with the simulation in the Experimental Zoom box of
Fig. 3. The sheep model predicted lower baseline temper-
ature of the brain than the body, while for the human,
comparable baseline temperatures were predicted for the
brain and body. Both models predicted a lowering of the
temperature of the brain and body following onset of
cooling from steady state conditions (i.e., after a settling
time of 100 min the cooling system started to work). The
thermodynamic model for the sheep predicted a cooling
rate of 0.4 C/h for the brain and 0.2 C/h for the body due
to the back flow of colder blood into the circulatory system.
To test the validity of the predicted data, the time series
of brain and body cooling temperatures were evaluated in 4
animals (Table 1). Baseline temperatures confirmed a
lower temperature of the brain compared to the body, with
Fig. 2 a Cooling collar wrapped around the neck of sheep after the
induction of anesthesia. The neck of the animal was shaved and covered
with a thin layer of conductive gel to improve heat transfer from the
neck to the device. Individual cooling elements were placed on the
tissues overlying carotid arteries (identified by Doppler scanning). The
device was connected to a control unit that controlled each cooling
element on the basis of the temperature feedback. b brain temperature
monitoring system consisted of an in situ PT-100 ATEX sensor. The
sensor was inserted 1 cm into the white matter between the parietal and
occipital lobe with a sagittal postero-anterior orientation through a burr
drilled into the right occipital bone, using a 1.5-mmball tool (Medtronic
Midas Rex surgical drill). The burr hole was sealed with sterile bone
wax. In the foreground a LiCox temperature sensor used to assess the
consistency of the temperature recordings of the reference sensor
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a mean baseline temperature of 36.5 (0.4) C for the brain
and 37.3 (0.3) C for the body. The experimental cooling
rate for the brain was 0.6 (0.2) C/h in line with the sim-
ulation, while the temperature reduction of the body was
slightly higher than predicted, 0.6 (0.2) C/h, likely due to
the metabolic reduction induced by general anesthesia, not
included into the simulation (Fig. 3). Indeed, the model
used the basal metabolic heat _Qm of 1200 kcal. Neverthe-
less, simulated temperatures fell within the confidence
interval of experimental data. As illustrated in Table 1, the
temperature variation, before and after application of the
cooling collar (i.e., at baseline and after 60 min), was
statistically significant, both for the brain (P = 0.0072) and
the body (P = 0.0090).
Heart rate (HR) and peripheral saturation of oxygen
(SpO2) were continuously monitored in all animals; inva-
sive arterial blood pressure (IABP) recordings were
Fig. 3 Sheep and human thermodynamic models, showing simulated
values of the time-dependent cooling of the brain (Th) and body (Tb)
induced by neck cooling. For the sheep, the simulated data were fitted
to the experimental data with their confidence intervals (Tbe and The,
blue symbols). The Experimental Zoom panel shows the experimental
temperature recordings and simulated temperatures with a better
resolution. The time from 0 to 100 min is the setting time required by
the model to reach the steady state. The sheep model confirmed lower
temperatures of the brain compared to the body, with baseline values
(at 100 min) of 36.5 (0.4) C for the brain and 37.3 (0.3) C for the
body. The experimental cooling rate for the brain was 0.6 (0.2) C/h
in line with the simulation (green line, in the zoom panel), while the
temperature reduction of the body was 0.6 (0.2) C/h, slightly higher
than predicted (red line, in the zoom panel). The temperature
variation, before and after application of the cooling collar (i.e., at
baseline and after 60 min), was statistically significant, both for the
brain (P = 0.0072) and the body (P = 0.0090). Temperatures are
expressed in C and time in min
Table 1 Average brain and body temperatures at baseline and after




at 60 min (C)
P value
Brain
Sheep 1 36.0 35.6
Sheep 2 36.5 35.9
Sheep 3 36.8 36.1
Sheep 4 36.8 36.4 0.0060
Body
Sheep 1 36.9 36.3
Sheep 2 37.1 36.6
Sheep 3 37.6 36.8
Sheep 4 37.5 37.1 0.0067
Temperatures were recorded with 1 Hz sampling rate; values are the
moving average at baseline and 3600 s
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available for two animals. Average baseline HR, IABP, and
SpO2 were 102.0 ± 13.6 bpm, 98.5 ± 9.2 mmHg,
98.0 ± 2.3 %and after 60 min of cooling 104.7 ± 6.2 bpm,
92.5 ± 10.6 mmHg, 97.8 ± 1.5 %: the differenceswere not
statistically significant for HR and SpO2 (P value 0.7252,
0.8619 respectively); statistical analysis was not performed
for IABP due to the limited number of available recordings.
The skin temperature under the cooling elements was
14.5 (0.5) C. There were no significant systemic side
effects of cooling during the experiments and no local
lesions at the interface between the cooling elements and
the skin of the neck.
By fitting the experimental data to the thermodynamic
model, we would predict a cooling rate for the brain of 0.64
and 0.43 C/h for the body for a 70 kg adult human subject
(Fig. 3).
Discussion
The present work suggests that effective brain cooling can
be achieved with an external cooling collar applied to the
neck surface to cool down the arterial vessels tributaries of
cerebral circulation, with negligible systemic side effects
and no skin lesions. This device has a sophisticated tem-
perature management system, able to regulate the intensity
and duration of brain cooling by modulating the tempera-
ture difference between the individual cooling elements
and the underlying tissues, blood vessels, and ultimately
blood. According to the thermodynamic model, in humans,
the efficiency of the neck as heat exchanger is expected to
be similar or even higher compared to the sheep.
The portable device for targeted brain cooling we
developed could be deployed in the field to induce early
on-site hypothermia, used for in-hospital maintenance of
mild hypothermia in the same patients, or for the treatment
of fever and temperature control in critically ill neurologic
patients.
Although early on-site hypothermia is an attractive
approach to improve outcomes after cardiac arrest, the
results of clinical studies on out-of-hospital hypothermia
provided conflicting results, possibly because of subopti-
mal methods of inducing hypothermia [7, 9]. The adoption
of a minimally invasive, portable cooling device such this
could offer first responders the opportunity to administer
effective hypothermia while providing emergency care,
and provide a therapeutic bridge until further treatments
can be accessed.
The present cooling system represents an attractive,
viable and cost-effective alternative to surface and
intravascular cooling methods for subjects suffering from
cardiac arrest and acute brain injury. While the prevention
of fever and the maintenance of normothermia are
recommended in the acute phase following traumatic brain
injury, stroke, and subarachnoid hemorrhage [15–17], the
optimal method to do so has not been identified yet.
Hypothermia is also useful for the control of elevated
intracranial pressure in patients with traumatic brain injury,
but this maneuver may be associated with detrimental side
effects and result in worse outcome [18]. Hence, another
potential application of the present device is as a ‘‘more
gentle’’ system to control the brain temperature and help in
the treatment of elevated intracranial pressure.
The thermodynamic model indicates that a target dif-
ferential temperature of 1–2 C can be attained within
2–4 h with this cooling device. Compared to whole-body
cooling methods, this is less effective in reducing the body
temperature, however with an improved safety profile. It is
well established that intravascular devices may be associ-
ated to complications such as vascular thrombosis [19, 20],
whereas the infusion of large volumes of cold fluids may
induce volume overload [7]. The experimental results
suggest a good safety profile of the device also in terms of
local skin injury. Sheep’s skin, however, is protected by a
layer of lanolin, which makes it more resistant than human
skin to environmental hazards like low temperature.
Therefore, the effects of the device on local skin will need
to be carefully tested in humans, to determine the minimum
feasible temperature in a clinical scenario.
Furthermore, safety monitoring will be fundamental
when moving on human subjects, to carefully check for
potential detrimental effects of the cooling collar on the
arterial blood flow dynamics (i.e., the transition from
laminar to turbulent flow), which may result in blood
hypercoagulability. Adequate brain imaging techniques
and/or non-invasive monitoring of the cerebral blood flow
for the early detection of ischemia (e.g., with echo color
Doppler or Near Infrared Spectroscopy NIRS) are therefore
recommended when conducting human studies.
Shivering is the most common effect of hypothermia, as
thermoceptors are mostly located on the exterior layers of
the human body, especially in the dermis. Surface cooling
devices suffer from a more intense thermoceptor stimula-
tion than invasive cooling systems. The limited surface of
our cooling system has the advantage of reducing the
number of thermoceptors involved with a potentially pos-
itive effect on shivering.
Notably, the rate of temperature reduction of 0.6 C/h
obtained with the cooling collar is better than 0.25 C/h
reported for other cooling methods utilized in a large trial
of 900 patients [4].
A number of devices have been investigated for elective
brain cooling, with the aim to minimize the side effects of
whole-body cooling. At present time, the evidence on the
clinical applicability of these methods (e.g., cooling hel-
mets, nasopharyngeal cooling and carotid intra-arterial
Neurocrit Care (2016) 25:464–472 469
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cooling) is limited, due to safety issues or very little effi-
ciency [10, 21].
The current design of our cooling system did not pro-
duce a selective effect on the brain, as it was however
predicted by the model, possibly due to the constant
backflow of cooled blood from the brain to the body, or to
the effects of general anesthesia on the basal metabolism of
both brain and body. However, this effect can be easily
counterbalanced by measures to limit body cooling, such as
the use of thermal blankets. Therefore, the cooling collar
has the potential to create and maintain separate tempera-
ture zones for the head and the body and, thereby, limit the
negative effects of body hypothermia while optimizing the
therapeutic effect of hypothermia and temperature control
on the target organ.
In humans, the model still predicts a more selective
effect on the brain compared to the body, with a temper-
ature difference of 0.2 C/h. In humans, unlike sheep, both
carotid and vertebral arteries can be targeted for cooling,
which, in combination with higher cerebral blood flow, are
expected to increase the efficiency of the neck as heat
exchanger. In addition, a more selective effect might be
related to the impact of general anesthesia on basal meta-
bolism [22]. The hypothesis is that under anesthesia
sheep’s body, whose mass is relatively bigger compared to
the brain, may have cooled down more, thus counteracting
the selective effects of the cooling device, whereas in
humans this effect is likely diminished. Second, cooling
during the first hours of general anesthesia is partly due to
redistribution from core to peripheral tissues; body
peripheral tissue mass is considerably larger than head and
may have absorbed proportionally more heat [22]. In
humans, however, where the mass of the brain is larger
compared to the body, we expect an opposite effect. Most
importantly, these data will have to be confirmed in a
human study.
The device did not produce any significant effect on
heart rate and blood pressure, compared to similar surface
devices [23]. These data, if confirmed also in humans,
would attest a more favorable safety profile compared to
other surface cooling devices [10].
The device was programmed to reduce skin temperature
no lower than 5 C, a safety threshold to prevent local
freezing. In the experimental setting, however, local skin
temperatures never reached this limit, being on average
about 14.5 C. These findings suggest that the device, still
a prototype, may need more cooling power to reach the
lowest programmed skin temperature, since the carotid
arteries act as a continuous source of heat that counter-
balances the cooling effect of the collar. This is also the
main functional mechanism of the collar—removing heat
from the blood supply of the brain while it flows through
the neck. Accordingly, when the collar was positioned not
directly in contact with the carotid arteries (i.e., in a portion
of the neck far from the vessels) the lowest temperature
was reached within about 10 min from activation. These
data, if confirmed in humans, will be important in the
definition of the temperature feedback control algorithm.
Engineering work is under way to refine the prototype and
set up a final, more potent device.
Due to the unavailability of suitable animal models to
test the effectiveness of the present neck cooling collar, we
used a sheep model despite its limitations which include:
brain size that is approximately 1/10th of the size of a
human brain; specific anatomical features of the neck that
allows only the carotid arteries to be reached by the direct
cooling action [24]; and a differential in body-to-brain
temperatures, with body temperature frequently higher than
that of the brain [25]. Based on anatomical and physio-
logical differences between sheep and humans, the
effectiveness of the cooling collar would arguably be
higher in humans than in sheep.
Interestingly, the thermodynamic model predicted
comparable temperatures for the brain and body in humans,
in contrast to the higher brain-to-body temperatures
reported in patients with acute brain damage [26]. It is well
documented that the regulation of brain temperature may
be impaired after major brain injury, whereas little is
known about healthy conditions [27]. Additional investi-
gation will be needed into the conditions of human brain
injury, as there are no models of brain injury in sheep,
whose data can be effectively used for human research.
Our study has several limitations including the limited
number of animals and the aforementioned limits of the
model itself. Regrettably, to date, we are not aware of a
suitable alternative whose characteristics, in terms of body
mass, anatomy of the neck and size of the brain, are
comparable to those of humans.
In the current experimental setting, the prototype devi-
ces were tested for a continuous use of 60 min due to the
cooling power available and the characteristics of the heat
dissipation system. Pilot data were recorded indicating that
the system did not show signs of performance degradation
even for longer periods (120 min).
In conclusion, our experiments demonstrate the feasi-
bility of using a non-invasive method to induce brain
hypothermia using the neck as a heat exchanger. However,
there is still no enough evidence that a brain selective
effect can be achieved. The portable cooling collar that we
developed could offer an advantage in terms of portability
and early operability also in out-of-hospital environments.
The next step is to undertake a trial of feasibility in
humans.
Proof of superiority of any cooling method above others
is still lacking, and there are currently no formal cost-
benefit analyses.
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